Long Term Progression Free Survival Achieved by Maintenance “Second–Line” Polychemotherapy with Gemcitabine/Paclitaxel in Metastatic Urothelial Cancer of the Renal Pelvis—A Case Report
Andreas Bannowsky, Hermann Ahlen, Klaus-Peter Jünemann

J. Cancer Ther. Vol.1 No.4, December 31, 2010
DOI:10.4236/jct.2010.14035

The Predictive Value of Germline Polymorphisms in Patients with NSCLC
Anneli Nygaard, Karen-Lise Spindler, Christa Nyhus, Rikke Andersen, Anders Jakobsen

J. Cancer Ther. Vol.1 No.4, December 31, 2010
DOI:10.4236/jct.2010.14034

Combined Treatment with Buserelin+Cabergoline in Patient with Prostate Cancer and Pituitary Macroprolactinoma
Gervain Mihály, Vörös Erika, Molnár Andor, Karcsú-Kis Gyöngyi, László Ferenc, László A. Ferenc

J. Cancer Ther. Vol.1 No.4, December 31, 2010
DOI:10.4236/jct.2010.14033

Immuno-Chemotherapy Using Repeated Vaccine Treatment Can Produce Successful Clinical Responses in Advanced Metastatic Melanoma
Brendon Coventry, Peter Hersey, Anne-Marie Halligan, Antonio Michele

J. Cancer Ther. Vol.1 No.4, December 31, 2010
DOI:10.4236/jct.2010.14032

17-(Allylamino)-17-Demethoxygeldanamycin Combination with Curcumin Selectively Targets Mitogen Kinase Pathway in A Human Neuroblastoma Cell Line
Taiyab Aftab, Kuppa Srinivas Usha, Subbarao Sreedhar Amere

J. Cancer Ther. Vol.1 No.4, December 30, 2010
DOI:10.4236/jct.2010.14031